|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jermal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu Q, Hu T, Zheng E, Deng X and Wang Z:
Prognostic role of the lymphocyte-to-monocyte ratio in colorectal
cancer: An up-to-date meta-analysis. Medicine (Baltimore).
96:e70512017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cragg GM and Newman DJ: Plants as a source
of anti-cancer agents. J Ethnopharmacol. 100:72–79. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Whitley AC, Stoner GD, Darby MV and Walle
T: Intestinal epithelial cell accumulation of the cancer preventive
polyphenol Ellagic acid-extensive binding to protein and DNA.
Biochem. Pharmacol. 66:907–915. 2003.
|
|
6
|
Aiyer HS, Vadhanam MV, Stoyanova R, Caprio
GD, Clapper ML and Gupta RC: Dietary berries and Ellagic acid
prevent oxidative DNA damage and modulate expression of DNA repair
genes. Int J Mol Sci. 9:327–341. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cho H, Jung H, Lee H, Yi HC, Kwak HK and
Hwang KT: Chemopreventive activity of ellagitannins and their
derivatives from black raspberry seeds on HT-29 colon cancer cells.
Food Funct. 6:28612015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mertens-Talcott SU, Lee JH, Percival SS
and Talcott ST: Induction of cell death in Caco-2 human colon
carcinoma cells by Ellagic acid rich fractions from muscadine
grapes. J Agric Food Chem. 54:5336–5343. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li LW, Na C, Tian SY, Chen J, Ma R, Gao Y
and Lou G: Ellagic acid induces HeLa cell apoptosis via regulating
signal transducer and activator of transcription 3 signaling. Exp
Ther Med. 16:29–36. 2018.PubMed/NCBI
|
|
10
|
Zhao JL, Li GD, Bo WL, Zhou YH, Dang SW,
Wei JF, Li XL and Liu M: Multiple effects of Ellagic acid on human
colorectal carcinoma cells identified by gene expression profile
analysis. Int J oncol. 50:613–621. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen HS, Bai MH, Zhang T, Li GD and Liu M:
Ellagic acid induces cell cycle arrest and apoptosis through
TGF-β/Smad3 signaling pathway in human breast cancer MCF-7 cells.
Int J Oncol. 46:1730–1738. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sung JJ, Lau JY, Young GP, Sano Y, Chiu
HM, Byeon JS, Yeoh KG, Goh KL, Sollano J, Rerknimitr R, et al: Asia
Pacific consensus recommendations for colorectal cancer screening.
Gut. 57:1166–1176. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ferlay J, Colombet M, Soerjomataram I,
Dyba T, Randi G, Bettio M, Gavin A, Visser O and Bray F: Cancer
incidence and mortality patterns in Europe: Estimates for 40
countries and 25 major cancers in 2018. Eur. J Cancer. 103:356–387.
2018.
|
|
15
|
Ceci C, Lacal PM, Tentori L, De Martino
MG, Miano R and Graziani G: Experimental Evidence of the antitumor,
antimetastatic and antiangiogenic activity of Ellagic acid.
Nutrients. 10(pii): E17562018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Umesalma S and Sudhandiran G: Differential
inhibitory effects of the polyphenol Ellagic acid on inflammatory
mediators NF-kappaB, iNOS, COX-2, TNF-alpha, and IL-6 in
1,2-dimethylhydrazine-induced rat colon carcinogenesis. Basic Clin
Pharmacol Toxicol. 107:650–655. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kong X, Ding X and Yang Q: Identification
of multi-target effects of Huaier aqueous extract via microarray
profling in triple-negative breast cancer cells. Int J Oncol.
46:2047–2056. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Heldin CH, Miyazono K and ten Dijke P:
TGF-beta signaling from cell membrane to nucleus through SMAD
proteins. Nature. 390:465–471. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Blobe GC, Schiemann WP and Lodish HF: Role
of transforming growth factor beta in human disease. N Engl J Med.
342:1350–1358. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Siegel PM and Massagué J: Cytostatic and
apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev
Cancer. 3:807–821. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pardali K and Moustakas A: Actions of
TGF-beta as tumor suppressor and pro-metastatic factor in human
cancer. Biochim Biophys Acta. 1775:21–62. 2007.PubMed/NCBI
|
|
22
|
Ikushima H and Miyazono K: TGFbeta
signaling: A complex web in cancer progression. Nat Rev Cancer.
10:415–424. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang T, Chen HS, Wang LF, Bai MH, Wang
YC, Jiang XF and Liu M: Ellagic acid exerts anti-proliferation
effects via modulation of TGF-β/Smad3 signaling in MCF-7 breast
cancer cells. Asian Pac J Cancer Prev. 15:273–276. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou X, Suzuki H, Shimada Y, Imamura M,
Yin J, Jiang HY, Tarmin L, Abraham JM and Meltzer S: Genomic DNA
and messenger RNA expression alterations of the CDKN2B and CDKN2
genes in esophageal squamous carcinoma cell lines. Genes
Chromosomes Cancer. 13:285–290. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hannon G and Beach D: p15INK4B is a
potential effector of TGF-beta-induced cell cycle arrest. Nature.
371:257–261. 1994. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Musgrove EA, Lilischkis R, Cornish AL, Lee
CS, Setlur V, Seshadri R and Sutherland RL: Expression of the
Cyclin-dependent kinase inhibitors p16INK4, p15INK4B and
p21WAF1/CIP1 in human breast cancer. Int J Cancer. 63:584–591.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Erickson S, Sangfelt O, Heyman M, Castro
J, Einhorn S and Grandér D: Involvement of the Ink4 proteins p16
and p15 in T-lymphocyte senescence. Oncogene. 17:595–602. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
McNeal AS, Liu K, Nakhate V, Natale CA,
Duperret EK, Capell BC, Dentchev T, Berger SL, Herlyn M, Seykora JT
and Ridky TW: CDKN2B loss promotes progression from benign
melanocytic nevus to melanoma. Cancer Discov. 5:1072–1085. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Malumbres M and Barbacid M: Mammalian
cyclin-dependent kinases. Trends Biochem. Sci. 30:630–641.
2005.
|
|
30
|
Tsai JH, Hsu LS, Huang HC, Lin CL, Pan MH,
Hong HM and Chen WJ: 1-(2-Hydroxy-5-methylphenyl)-3-phenyl-1,
3-propanedione Induces G1 cell cycle arrest and autophagy in HeLa
cervical cancer cells. Int J Mol Sci. 17(pii): E12742016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Derynck R, Zhang Y and Feng XH: Smads:
Transcriptional activators of TGF-beta responses. Cell. 95:737–740.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Miyazono K, ten Dijke P and Heldin CH:
TGF-beta signaling by Smad proteins. Adv Immunol. 75:115–157. 2000.
View Article : Google Scholar : PubMed/NCBI
|
